The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) grew by 19% during the week ended 19 April, 2020, compared to the previous week, according to GlobalData’s deals database.

Aurojyoti Bose, Analyst at GlobalData, comments: “Deal activity has remained inconsistent since the COVID-19 outbreak. However, the healthcare sector has shown relatively better performance compared to other sectors.”

Deal activity increased in key markets such as the US and China during the week, while the announcement of venture financing, partnership and equity offering deals increased by 45.5%, 6.7% and 46.4%, respectively. Mergers and acquisitions (M&A), licensing agreement and private equity deal volume remained at the same level.